BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12748676)

  • 1. Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: implications for minimal residual disease detection post-transplant.
    Rosenblum MD; Drobyski WR; Keever-Taylor C; Chang CC
    Bone Marrow Transplant; 2003 May; 31(10):947-9. PubMed ID: 12748676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells.
    McGregor DK; Keever-Taylor CA; Bredeson C; Schur B; Vesole DH; Logan B; Chang CC
    Bone Marrow Transplant; 2005 Jun; 35(11):1049-54. PubMed ID: 15821762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection and diagnostic value of t(14;18) translocation in minimal residual disease of follicular lymphoma].
    Bessenyei B; Urbán L; Takács I; Zeher M; Szegedi G; Semsei I
    Orv Hetil; 2000 Jul; 141(31):1715-9. PubMed ID: 10976195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphoma.
    von Neuhoff N; Dreger P; Suttorp M; Marget M; Kell S; Schmitz N
    Bone Marrow Transplant; 1998 Jul; 22(2):161-6. PubMed ID: 9707024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
    Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation.
    Darby A; Gribben JG
    Methods Mol Med; 2005; 115():315-31. PubMed ID: 15998976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of real-time PCR in long-term follow-up of follicular lymphoma patients.
    Tysarowski A; Fabisiewicz A; Paszkiewicz-Kozik E; Kulik J; Walewski J; Siedlecki JA
    Acta Biochim Pol; 2007; 54(1):135-42. PubMed ID: 17351675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of residual disease in follicular lymphomas using the PCR technique: importance of clono-specific probes].
    al Saati T; Galoin S; Roda D; Huynh A; Attal M; Delsol G
    Bull Cancer; 1998 Oct; 85(10):847-54. PubMed ID: 9835862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment.
    Pappa VI; Wilkes S; Salam A; Young BD; Lister TA; Rohatiner AZ
    Bone Marrow Transplant; 1998 Sep; 22(6):553-8. PubMed ID: 9758342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation.
    Hirt C; Dölken G
    Bone Marrow Transplant; 2000 Feb; 25(4):419-26. PubMed ID: 10723586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
    Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
    Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Practical aspects and clinical value of t(14;18) monitoring in peripheral blood of the follicular lymphoma patients].
    Janíková-Oborilová A; Mayer J; Dvorákova D; Mejstrík P; Navritíl M; Vásová I; Kren L; Matuska M
    Cas Lek Cesk; 2007; 146(4):374-81; discussion 381-2. PubMed ID: 17491248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult T-cell leukemia successfully treated with allogeneic bone marrow transplantation.
    Tajima K; Amakawa R; Uehira K; Matsumoto N; Shimizu T; Miyazaki Y; Fujimoto M; Kishimoto Y; Fukuhara S
    Int J Hematol; 2000 Apr; 71(3):290-3. PubMed ID: 10846838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course.
    Chang CC; Bredeson C; Juckett M; Logan B; Keever-Taylor CA
    Bone Marrow Transplant; 2003 Aug; 32(3):287-91. PubMed ID: 12858200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
    Deggerdal AH; Pettersen F; Kvalheim G; Hornes E; Smeland E; Fodstad O; Hovig E
    Lab Invest; 1995 Apr; 72(4):411-8. PubMed ID: 7723279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
    Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
    Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and quantification of MBR/JH2 t(14;18) BCL-2 gene rearrangement in follicular lymphoma using a combined real-time polymerase chain reaction assay.
    Csernák E; Tóth E; Melegh Z; Schneider T; Rosta A; Szentirmay Z
    Haematologica; 2006 Jun; 91(6):858-9. PubMed ID: 16704964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.
    Sørensen CD; Jørgensen JM; Nederby L; Hokland P; Nyvold CG
    J Immunol Methods; 2014 Apr; 406():131-6. PubMed ID: 24631717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
    Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
    Kornacker M; Kornacker B; Schmitt C; Leo E; Ho AD; Hensel M
    Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.